Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
During crashes, passive index funds typically deliver steadier exposure and lower fees, while active funds may outperform briefly but incur higher risks and costs.
24,770 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
With whispers of funded shortfalls, retirees social security just may face tighter benefits. This guide breaks down w...
SpaceX's S-1 filing exposes Bitcoin exposure and a broader digital-asset playbook, signaling a new price benchmark fo...
A fresh government outlook puts social security's insolvency date at the end of 2032, prompting talks of payroll tax ...
Rivian priced a 75 million share secondary offering, sending its stock down around 14% and triggering a market-wide p...
Benchmark analysts cheer Strategy’s pivot to STRC as the primary funding engine for bitcoin accumulation, signaling a...
XRP exchange-traded funds booked their first monthly net outflow after a $1.2 billion rally, signaling a shift in inv...
A potential agreement with Iran could unlock sanctions relief, release frozen assets, and reopen Gulf shipping. Negot...
SpaceX’s impending IPO is driving the launch of leveraged ETFs designed to amplify bets on the rocket company, offeri...
BonkDAO’s governance proposal drained roughly $20 million in BONK from its treasury, underscoring a new risk surface ...
Institutional traders are piling into XRP spot buying while the futures market cools, signaling a pivot in market par...
One of Wall Street’s hottest hedge funds is riding a two-trade surge, concentrated in Nvidia and Meta Platforms, as i...